Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify ESCC patients SANTA CLARA, Calif., July 31, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC... Read more
https://www.mt.com:80/content/us/en/home/supportive_content/press-releases/Control_and_Boost_Productivity.html Read more
Quick Order Contact Account View Cart (0) Log In Why FCDI Partners & Providers FCDI Customer Stories Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services Cardiac Cells iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiomyocytes Diversity Panel MyCell Cardiomyocytes Brugada iCell Cardiomyocytes CPVT (E2311D) MyCell Cardiomyocytes DCM (L35P) MyCell Cardiomyocytes... Read more
Madison, WI USA. (June 26, 2019) Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices and resulting trends through the previous year. The 2019 report documents how, over the last three years, an overall culture of sustainability resulted in an 8% reduction in the company’s carbon-to-revenue footprint. “We not... Read more
New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications BARCELONA, Spain – SLAS EUROPE 2019 – (June 26, 2019) – As the pharmaceutical industry continues to increase its focus on the development of biologics,... Read more
Göttingen, Germany | Yauco, Puerto Rico – June 18, 2019 Investment of more than 100 million U.S. dollars Area designed for future growth After investing more than 100 million U.S. dollars, Sartorius, a leading international partner of biopharmaceutical research and the industry, started up its expanded manufacturing operations in Yauco, Puerto Rico. The U.S. market is... Read more
New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) today announced the opening of a production facility in Colorado that more than doubles its capacity to develop and manufacture “oligos,” which are short DNA and... Read more
Development of customized drug discovery assays and image analyses upon request June 13, 2019 Nikon Corporation (Toshikazu Umatate, President, Tokyo) and its subsidiary Nikon Instruments Inc. (Toshiaki Nagano, President, NY, USA) have established the Nikon BioImaging Lab in Boston, USA to provide contract imaging and assay services for pharmaceutical companies and venture companies involved in... Read more
Medidata Solutions’ market-leading clinical cloud solutions are used by 1,300 customers worldwide to develop their therapeutic innovations and clinical operations performance •Scientific modeling, simulation and digital assets of worldwide trials knowledge and know-how combine to accelerate developments in personalized health, for the benefit of the patient •Life Sciences industry will also benefit from the platform effect spanning... Read more
Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., June 11, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration... Read more